Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines

Journal of Immunological Methods

Volumn 350, Issue 1-2, 2009, Pages 142-149

  Coombes, Laura ^a   Stickings, Paul ^a   Tierney, Rob ^a   Rigsby, Peter ^a   Sesardic, Dorothea ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Adsorption; Antigen; Combination; Diphtheria; Toxoid; Vaccine

Indexed keywords

ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MONOCLONAL ANTIBODY; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; POLYCLONAL ANTIBODY; TETANUS TOXOID;

ADSORPTION; ANIMAL EXPERIMENT; ARTICLE; DIPHTHERIA; DRUG MONITORING; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIG; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANIMALS; DIPHTHERIA TOXOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUINEA PIGS; HUMANS; RATS; SENSITIVITY AND SPECIFICITY; VACCINES, COMBINED;

ANIMALIA;

EID: 70349741294     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.09.002     Document Type: Article

References (29)

1. Bolgiano B., Fowler S., Turner K., Sesardic D., Xing D.K.L., Crane D.T., and Corbel M.J. Monitoring of diphtheria, pertussis and tetanus toxoid by circular dichroism, fluorescence spectroscopy and size-exclusion chromatography. In: Brown F., Corbel M.J., and Griffiths E. (Eds). Physico-chemical Procedures for the Characterization of Vaccines (2000), S. Karger AG, Basel 51
2. Castle P. Combined vaccines - policy and practice in the European Pharmacopeia. Biologicals 22 (1994) 381
3. Chovel Cuervo M.L., Sterling A.L., breu Nicot I., García Rodríguez M., and Rodríguez García O. Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers. Biologicals 36 (2008) 375
4. Claassen I., Maas R., Oei H., Daas A., and Milne C. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of Newcastle Disease Vaccine and to establish the suitability of a candidate biological reference preparation. Pharm. Biol. 2004 (2004) 1
5. Corbel M.J., Das R.G., Lei D., Xing D.K.L., Horiuchi Y., and Dobbelaer R. WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland. Vaccine 26 (2008) 1913
6. Council of Europe. 2.7.6 Assay of diphtheria vaccine (adsorbed). European Pharmacopoeia (6.0) (2008), EDQM 217
7. Council of Europe. Vaccines for human use. European Pharmacopoeia (6.3) (2009), EDQM 3971
8. Galazka A.M. The Immunological Basis for Immunization. Module 2: Diphtheria. WHO/EPI/GEN/93.12 (1993), World Health Organisation, Geneva
9. Giffroy D., Mazy C., and Duchêne M. Validation of a new ELISA method for in vitro potency assay of hepatitis B-containing vaccines. Pharm. Biol. 2006 (2006) 7
10. Glenny A.T., and Hopkins B.E. Diphtheria toxoid as an immunising agent. Br. J. Exp. Pathol. 4 (1923) 283
11. Gupta R.K., Rost B.E., Relyveld E., and Siber G.R. Adjuvant properties of aluminum and calcium compounds. In: Powell M.F., and Newman M.J. (Eds). Vaccine Design: the Subunit and Adjuvant Approach (1995), Plenum Press, New York 229
12. Hendriksen C.F.M. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement. Exp. Rev. Vaccines 8 (2009) 313
13. Hendriksen C., Arciniega J.L., Bruckner L., Chevalier M., Coppens E., Descamps J., Duchêne M., Dusek D.M., Halder M., Kreeftenberg H., Maes A., Redhead K., Ravetkar S.D., Spieser J.M., and Swam H. The consistency approach for the quality control of vaccines. Biologicals 36 (2008) 73
14. Jódar L., Griffiths E., and Feavers I. Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines. Vaccine 22 (2004) 1047
15. Kreeftenberg J.G. Consistency testing of diphtheria and tetanus to replace potency testing for lot release. In: Brown F., Hendriksen C., Sesardic D., and Cussler K. (Eds). Advancing Science and Elimination of the Use of Laboratory Animals for Development and Control of Vaccines and Hormones (2002), S. Karger AG, Basel 291
16. Leenaars P.P.A.M., Kersten G.F.A., de Bruijn M.L.H., and Hendriksen C.F.M. An in vitro approach in quality control of toxoid vaccines. Vaccine 19 (2001) 2729
17. Matheis W., Zott A., and Schwanig M. The role of the adsorption process for production and control combined adsorbed vaccines. Vaccine 20 (2001) 67
18. Metz B., Hendriksen C.F.M., Jiskoot W., and Kersten G.F.A. Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 20 (2002) 2411
19. Metz B., Jiskoot W., Hennink W.E., Crommelin D.J.A., and Kersten G.F.A. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine 22 (2003) 156
20. Metz B., Brunel F., Chamberlin C., van der Gun J., Halder M., Jiskoot W., Kersten G., van Opstal O., Petersen J.W., Ravetkar S.D., Redhead K., Schwanig M., Wilhelmsen E.S., Vann W.F., and Hendriksen C. The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines - the report and recommendations of ECVAM workshop 61(a). ATLA. Altern. Lab. Anim. 35 (2007) 323
21. Metz B., Jiskoot W., Mekkes D., Kingma R., Hennink W.E., Crommelin D.J.A., and Kersten G.F.A. Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques. Vaccine 25 (2007) 6863
22. Preneta-Blanc R., Rigsby P., Wilhelmsen E.S., Tierney R., Brierley M., and Sesardic D. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test. Biologicals 36 (2008) 315
23. Prieur S., Broc S., Gal M., Poirier B., and Fuchs F. Development of an in vitro potency test for tetanus vaccines. In: Brown F., Hendriksen C., Sesardic D., and Cussler K. (Eds). Advancing Science and Elimination of the Use of Laboratory Animals for Development and Control of Vaccines and Hormones (2002), S. Karger AG, Basel 37
24. Ramon G. Sur la toxine et sur l'anatoxine diphtériques. Ann. Inst. Pasteur 38 (1924) 1
25. Sesardic D., Dawes C.S., Mclellan K., Durrani Z., Yost S.E., and Corbel M.J. Non-pertussis components of combination vaccines: problems with potency testing. Biologicals 27 (1999) 177
26. WHO Expert Committee on Biological Standardization. Annex 5, recommendations for diphtheria, tetanus, pertussis and combined vaccines (Amendments 2003). Fifty-fourth report. Technical Report Series No 927 (2005), World Health Organization, Geneva 138
27. Winsnes R., Sesardic D., Daas A., and Behr-Gross M.-E. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-Part 1. Pharm. Biol. 2003 (2004) 35
28. Winsnes R., Sesardic D., Daas A., and Behr-Gross M.-E. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines (Part 2). Pharm. Biol. 2006 (2006) 73
29. Xing D.K.L., McLellan K., Corbel M.J., and Sesardic D. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. Biologicals 24 (1996) 57